or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Safeguarding America's Pharmaceuticals Act of 2013

Floor Speech

By:
Date:
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. PASCRELL. Mr. Speaker, as the House considers H.R. 1919, the Safeguarding America's Pharmaceuticals Act of 2013, I would like to voice my specific concerns with one provision within the legislation. While the underlying bill seeks to address the issue of preventing counterfeit drugs from reaching consumers, and improving national regulatory standards for pharmaceuticals, Section 8 of the proposed legislation instead mandates an electronic labeling requirement for pharmaceuticals. This serves to eliminate hard copy professional literature, and transition exclusively to electronic only literature. Based on legislation passed by Congress in 2012, GAO was tasked with studying the issue of e-labeling. This study is expected to be issued in July of this year. I urge my colleagues to carefully consider the potential ramifications of exclusive electronic labeling, and be cautious about any premature legislative action on this issue until the GAO report is released. The findings of this Congressionally mandated study should be deliberated before making a change that has the potential to impact consumers and providers.

BREAK IN TRANSCRIPT


Source:
Back to top